In a report published Wednesday, Credit Suisse analyst Ravi Mehrotra reiterated an Outperform rating on Celgene Corporation CELG, and raised the price target from $113.00 to $125.00.
In the report, Credit Suisse noted, “Post this week's PII data for Mongersen (aka GED-0301), we are increasing our peak sales estimates to $3B (from $2B) and concomitantly increasing CELG TP to $125 (from $113).”
Celgene Corporation closed on Tuesday at $94.97.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in